Latest issue of UTRF Newsletter spotlights Jonathan Wall and team
The latest issue of the University of Tennessee (UT) Research Foundation’s monthly newsletter spotlights the work of Jonathan Wall and the team he leads at the UT Graduate School of Medicine (GSM).
As noted in this recent teknovation.biz article, Wall, Professor and Director of Research at the GSM, has spent about 25 years studying amyloidosis. San Francisco-based Attralus, a UT licensee of the technology that Wall and the team developed, recently secured $25 million in investment financing to work on transformative medicines to improve the lives of patients with systemic amyloidosis.
You can learn more about the work of the team in this “Inventor Spotlight” article.
